An AI-powered biomarker based on histology alone predicted survival among men with metastatic hormone-sensitive prostate cancer and identified those who benefitted from escalation to triplet therapy.

The prostate is the single organ most frequently afflicted by cancer in men. Prostate cancer affects approximately 4 million ...

New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors ...

September marks the beginning of National Prostate Cancer Awareness Month in the United States.

Reginald Tucker-Seeley, MA, ScM, ScD, concludes the program with advice for caregivers and patients with prostate cancer to maximize the benefit of treatment. This is a synopsis of an Educated Patient ...

Tiny silica nanoparticles engineered to seek out prostate cancer caused tumor cells to self-destruct and supercharged the ...

New research suggests that low handgrip strength alone is not a reliable predictor of increased prostate cancer risk among older men. The relationship between low handgrip strength (HGS) and prostate ...

According to the institute, a single, reliable test to differentiate aggressive, life-threatening cancers from slower-growing ...

CorePlus, Puerto Rico’s fully digital precision pathology and clinical laboratory, announced today the integration of the ...

Men diagnosed with metastatic hormone-sensitive prostate cancer who carry a specific tumor deficiency now have a targeted ...